Poland: official position of the competent authority on consequences for medical devices in the event of a no-deal brexit

Published date05 March 2019
Law FirmHogan Lovells
AuthorAgnieszka Majka
Subject MatterHealthcare,Medical Devices,Life Sciences,EU,Medical Reimbursement,Biosimilars,Regulatory Standards,UK,Poland,UK Brexit,Pharmaceutical Industry,No-Deal Brexit

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT